$35.23
Price
$1.1B
Market Cap
17.1
P/E Ratio
4.6
Forward P/E
$2.06
EPS (TTM)
—
Dividend Yield
$422M
Cash
$815M
Total Debt
32M
Shares Out
$29.19
$50.79
52-Week Range
Institutional Ownership of COLLEGIUM PHARMACEUTICAL INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Third Avenue Management|Matthew Fine
|
155.1K | $5M | $30.13 | +56.34% |
Trading Activity for COLLEGIUM PHARMACEUTICAL INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -23.7% | 155.1K | $5M | $45.28 | |
| 2024-Q4 | |||||
| BUY | +11.4% | 203.4K | $6M | $31.33 | |
| 2024-Q3 | |||||
| BUY | +0.2% | 182.7K | $7M | $36.08 | |
| 2024-Q2 | |||||
| BUY | +68.6% | 182.3K | $6M | $34.25 | |
| 2024-Q1 | |||||
| BUY | +30.1% | 108.1K | $4M | $33.49 | |
| 2023-Q4 | |||||
| BUY | NEW | 83.1K | $3M | $25.11 | |
Insider Trading for COLLEGIUM PHARMACEUTICAL INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.